Status:
RECRUITING
Development of Clinical and Biological Database
Lead Sponsor:
Institut du Cancer de Montpellier - Val d'Aurelle
Conditions:
Digestive Cancer
Gynecologic Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The BCB is a tool: * for research in analytical and public health epidemiology, biological research and for the development of data useful for clinical research and therapeutic trials; * to help scie...
Detailed Description
Implementation of a translational research project is part of the Cancer Plan 2014-2019 and its axis 5 "Advancing clinical and translational research in oncology", and more precisely Action 5.1. The ...
Eligibility Criteria
Inclusion
- Age\> at 18 years old,
- Patient with invasive or in situ tumor pathology (proven or suspected) any stage confounded,
- Patient in ICM at diagnosis
- a digestive cancer (esophagus, stomach, pancreas, colon, rectum, anal canal) or
- gynecological cancer (ovary, endometrium, cervix) or
- breast cancer or
- sarcoma.
- Naïve patient of any treatment for the present cancer,
- Patient requiring treatment involving at least one (or more) tumor surgery (s)
- Patient who has accepted supplementary blood samples,
- Patient having given his informed, written and express consent.
Exclusion
- Patient not affiliated to a social protection scheme,
- Patient whose regular follow-up is a priori impossible for psychological, familial, social or geographical reasons,
- Pregnant and / or nursing women,
- Subject under tutelage, curatorship or safeguard of justice,
- Patient in an emergency situation.
Key Trial Info
Start Date :
July 27 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2037
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT03449264
Start Date
July 27 2017
End Date
November 1 2037
Last Update
February 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut regional du Cancer - Val d Aurelle
Montpellier, France, 34298